HEALTH NEWS

Study Title:

Pyrroloquinoline quinone prevents testosterone deficiency-induced osteoporosis b

Study Abstract

Pyrroloquinoline quinone prevents testosterone deficiency-induced osteoporosis by stimulating osteoblastic bone formation and inhibiting osteoclastic bone resorption. 

Study Information

Am J Transl Res. 2017 Mar 15;9(3):1230-1242. PMID: 28386349; PMCID: PMC5376014.

Full Study

https://pubmed.ncbi.nlm.nih.gov/28386349/
Monthly Sale

February Sale

Improve circulation, lipid health, and cardiovascular fitness.